GTPL7939

99%

Reagent Code: #62658
fingerprint
CAS Number 1224887-10-8

science Other reagents with same CAS 1224887-10-8

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 414.89 g/mol
Formula C₂₀H₂₃ClN₆O₂
badge Registry Numbers
MDL Number MFCD30502650
inventory_2 Storage & Handling
Storage -20℃

description Product Description

GTPL7939 is a potent, reversible, cell-permeable, and selective allosteric inhibitor of PI3Kα (phosphoinositide 3-kinase α; IC50 = 1.3 nM), displaying >300-fold selectivity over other class I PI3K isoforms, mTOR, DNA-PK, and PI4Ks. This specialty research chemical is investigated in oncology for inhibiting proliferation of PI3Kα/PTEN-driven cancer cells, tumor growth, and metastasis. It is studied as a targeted therapy candidate and for synergy with chemotherapy to improve outcomes. Preclinical research assesses its pharmacokinetics, safety, and effects on cancer signaling pathways.

format_list_bulleted Product Specification

Test Parameter Specification
Appearance White to Khaki Powder
Purity (%) 98.5-100
Infrared Spectrum Conforms to Structure
NMR Conforms to Structure

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 5mg
10-20 days ฿6,966.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
GTPL7939
No image available

GTPL7939 is a potent, reversible, cell-permeable, and selective allosteric inhibitor of PI3Kα (phosphoinositide 3-kinase α; IC50 = 1.3 nM), displaying >300-fold selectivity over other class I PI3K isoforms, mTOR, DNA-PK, and PI4Ks. This specialty research chemical is investigated in oncology for inhibiting proliferation of PI3Kα/PTEN-driven cancer cells, tumor growth, and metastasis. It is studied as a targeted therapy candidate and for synergy with chemotherapy to improve outcomes. Preclin

GTPL7939 is a potent, reversible, cell-permeable, and selective allosteric inhibitor of PI3Kα (phosphoinositide 3-kinase α; IC50 = 1.3 nM), displaying >300-fold selectivity over other class I PI3K isoforms, mTOR, DNA-PK, and PI4Ks. This specialty research chemical is investigated in oncology for inhibiting proliferation of PI3Kα/PTEN-driven cancer cells, tumor growth, and metastasis. It is studied as a targeted therapy candidate and for synergy with chemotherapy to improve outcomes. Preclinical research assesses its pharmacokinetics, safety, and effects on cancer signaling pathways.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...